Pareto 20logo 20rgb

Pareto Biotechnologies, Inc.

Pareto was founded to further develop a patent-protected synthetic biology / chemistry technology platform to replace petrochemically-derived chemical products.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Emeryville, CA, USA
  • Currency USD
  • Founded September 2012
  • Employees 2
  • Website

Company Summary

Pareto Biotechnologies helps flavor and fragrance companies create value by making products that are considered natural, using enzyme and chemical engineering technologies from the Salk Institute and University of Wisconsin. The founders have deep experience in biofuels and renewable chemicals. The company has initial funding from Breakout Labs (part of the Thiel Foundation) and DNA2.0 (world leader in gene synthesis and bioengineering).


  • 13fc1139 5fcb 4559 8749 c643f4c242fb
    Founder & CEO

    Extensive experience in biofuels and renewable chemicals. Most recently at Total New Energies (part of Total, the French energy company, fifth largest energy company in the world) co-leading the ~$100MM collaboration with Amyris, a local biofuels company.

  • Default avatar
    Mike Burkart
    Founder & SAB

    Dr. Michael Burkart is a Professor of Chemistry and Biochemistry at the University of California, San Diego, and an Associate Director of the California Center for Algae Biotechnology. An internationally recognized expert in natural product biosynthesis and metabolic pathway engineering, his areas of expertise include natural product synthesis and biosynthesis, enzyme mechanism, and metabolic engineering.

  • Default avatar
    Joe Noel
    Founder & SAB Chair

    Joe is the inventor of Pareto’s foundational technology, and has a strong record of creating consumer goods, notably as a co-founder of renewable chemicals company Allylix. Joe is a HHMI Investigator, a professor in the Structural Biology Laboratory at the Salk Institute for Biological Studies, and Director of the Jack Skirball Center for Chemical Biology and Proteomics at the Salk Institute for Biological Studies in La Jolla.

  • Default avatar
    Mike Mendez
    Founder & CTO

    With over 25 years of experience in biotechnology start-ups, Mike Mendez is a serial entrepreneur who has a demonstrated talent for developing technology platforms. He has been part of nine start-ups, four of which he founded. Most recently, Mike co-founded Sapphire Energy as VP of Technology; he was also the lead inventor of the 'xenomouse', a mouse with a humanized immune system, that was ultimately purchased by Amgen for over $2B.

Previous Investors

  • Default avatar
    Breakout Labs - $350,000
    Default avatar
    Andras Forgacs
    advisor / CEO of Modern Meadow